JP2010116400A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010116400A5 JP2010116400A5 JP2009284587A JP2009284587A JP2010116400A5 JP 2010116400 A5 JP2010116400 A5 JP 2010116400A5 JP 2009284587 A JP2009284587 A JP 2009284587A JP 2009284587 A JP2009284587 A JP 2009284587A JP 2010116400 A5 JP2010116400 A5 JP 2010116400A5
- Authority
- JP
- Japan
- Prior art keywords
- polymorphism
- stem cells
- ccr5
- composition
- ccr5δ32
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 101710149870 C-C chemokine receptor type 5 Proteins 0.000 claims 16
- 210000000130 stem cell Anatomy 0.000 claims 16
- 102100035875 C-C chemokine receptor type 5 Human genes 0.000 claims 15
- 239000000203 mixture Substances 0.000 claims 11
- 108090000623 proteins and genes Proteins 0.000 claims 8
- 108700039691 Genetic Promoter Regions Proteins 0.000 claims 5
- 208000031886 HIV Infections Diseases 0.000 claims 4
- 208000037357 HIV infectious disease Diseases 0.000 claims 4
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims 4
- 210000000577 adipose tissue Anatomy 0.000 claims 3
- 210000001185 bone marrow Anatomy 0.000 claims 3
- 210000004700 fetal blood Anatomy 0.000 claims 3
- 210000001161 mammalian embryo Anatomy 0.000 claims 3
- 210000005259 peripheral blood Anatomy 0.000 claims 3
- 239000011886 peripheral blood Substances 0.000 claims 3
- 230000003169 placental effect Effects 0.000 claims 3
- 238000000338 in vitro Methods 0.000 claims 2
- 238000001727 in vivo Methods 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 210000001616 monocyte Anatomy 0.000 claims 1
- 102000054765 polymorphisms of proteins Human genes 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/998,832 | 2001-11-29 | ||
| US09/998,832 US20030099621A1 (en) | 2001-11-29 | 2001-11-29 | Stem cell screening and transplantation therapy for HIV infection |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003546840A Division JP2005519877A (ja) | 2001-11-29 | 2002-11-27 | Ｈｉｖ感染のための幹細胞スクリーニングおよび移植治療 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012215505A Division JP5829993B2 (ja) | 2001-11-29 | 2012-09-28 | Ｈｉｖ感染に対する幹細胞スクリーニングおよび移植治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010116400A JP2010116400A (ja) | 2010-05-27 |
| JP2010116400A5 true JP2010116400A5 (https=) | 2011-03-31 |
| JP5675088B2 JP5675088B2 (ja) | 2015-02-25 |
Family
ID=25545599
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003546840A Withdrawn JP2005519877A (ja) | 2001-11-29 | 2002-11-27 | Ｈｉｖ感染のための幹細胞スクリーニングおよび移植治療 |
| JP2009284587A Expired - Lifetime JP5675088B2 (ja) | 2001-11-29 | 2009-12-15 | Ｈｉｖ感染に対する幹細胞スクリーニングおよび移植治療 |
| JP2012215505A Expired - Fee Related JP5829993B2 (ja) | 2001-11-29 | 2012-09-28 | Ｈｉｖ感染に対する幹細胞スクリーニングおよび移植治療 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003546840A Withdrawn JP2005519877A (ja) | 2001-11-29 | 2002-11-27 | Ｈｉｖ感染のための幹細胞スクリーニングおよび移植治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012215505A Expired - Fee Related JP5829993B2 (ja) | 2001-11-29 | 2012-09-28 | Ｈｉｖ感染に対する幹細胞スクリーニングおよび移植治療 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20030099621A1 (https=) |
| EP (1) | EP1469888B1 (https=) |
| JP (3) | JP2005519877A (https=) |
| AU (1) | AU2002353006A1 (https=) |
| WO (1) | WO2003045335A2 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003298775B2 (en) | 2002-11-26 | 2008-07-17 | Anthrogenesis Corporation | Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
| JP2009502176A (ja) * | 2005-07-28 | 2009-01-29 | イーデン バイオテック リミティド | 免疫系の再生方法 |
| ES2882360T3 (es) | 2006-11-03 | 2021-12-01 | Univ Leland Stanford Junior | Inmunoempobrecimiento selectivo de un nicho de células madre endógenas para injerto |
| SG10201509679XA (en) | 2007-05-29 | 2015-12-30 | Christopher B Reid | Methods for production and uses of multipotent cell populations |
| US20140127313A1 (en) * | 2011-06-29 | 2014-05-08 | Ronilu Development Corporation | Prevention and treatment of hiv infection |
| US10669547B2 (en) | 2013-03-15 | 2020-06-02 | Kambiz Shekdar | Genome editing using effector oligonucleotides for therapeutic treatment |
| RU2563172C1 (ru) * | 2014-11-12 | 2015-09-20 | Общество с ограниченной ответственностью "Покровский банк стволовых клеток" | СПОСОБ ОПРЕДЕЛЕНИЯ АЛЛЕЛЬНОГО ПОЛИМОРФИЗМА CCR5 delta 32 |
| US10426796B2 (en) * | 2016-06-13 | 2019-10-01 | SMART SURGICAL, Inc. | Compositions for biological systems and methods for preparing and using the same |
| US10456423B2 (en) | 2016-06-13 | 2019-10-29 | SMART SURGICAL, Inc. | Compositions for biological systems and methods for preparing and using the same |
| EP3579850A4 (en) * | 2017-02-10 | 2020-11-25 | Abraham J and Phyllis Katz Cord Blood Foundation | METHODS FOR TREATING HIV INFECTION WITH ALLOGENIC UMBILICAL CORD BLOOD CELLS |
| EP3490605B1 (en) * | 2017-04-01 | 2023-06-07 | AVM Biotechnology, LLC | Replacement of cytotoxic preconditioning before cellular immunotherapy |
| MX2020004811A (es) * | 2017-11-15 | 2020-10-07 | Weird Science Llc | Métodos y composiciones de reconstrucción no mieloablativa de médula ósea. |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| US4517288A (en) | 1981-01-23 | 1985-05-14 | American Hospital Supply Corp. | Solid phase system for ligand assay |
| CA1291031C (en) | 1985-12-23 | 1991-10-22 | Nikolaas C.J. De Jaeger | Method for the detection of specific binding agents and their correspondingbindable substances |
| CA2065029A1 (en) * | 1989-09-14 | 1991-03-15 | Ellen S. Vitetta | Therapeutic compositions; methods for treatment of hiv infections |
| US6217867B1 (en) * | 1993-09-13 | 2001-04-17 | University Of Pittsburgh | Non-lethal methods for conditioning a recipient for bone marrow transplantation |
| US6153431A (en) * | 1997-05-30 | 2000-11-28 | Fond Mondiale Rech & Prev Sida | Human immunodeficiency virus co-receptor variants associated with resistance to virus infection |
| ATE329022T1 (de) * | 1997-08-14 | 2006-06-15 | Us Gov Health & Human Serv | Verzögerter fortschritt von aids durch missense allel des ccr2 gens |
| US6093531A (en) * | 1997-09-29 | 2000-07-25 | Neurospheres Holdings Ltd. | Generation of hematopoietic cells from multipotent neural stem cells |
| US20020048786A1 (en) * | 2000-02-09 | 2002-04-25 | Rosen Craig A. | Human G-protein Chemokine Receptor HDGNR10 |
| US20030017587A1 (en) * | 2001-07-18 | 2003-01-23 | Rader William C. | Embryonic stem cells, clinical applications and methods for expanding in vitro |
-
2001
- 2001-11-29 US US09/998,832 patent/US20030099621A1/en not_active Abandoned
-
2002
- 2002-11-27 JP JP2003546840A patent/JP2005519877A/ja not_active Withdrawn
- 2002-11-27 US US10/498,450 patent/US20050220772A1/en not_active Abandoned
- 2002-11-27 WO PCT/US2002/038436 patent/WO2003045335A2/en not_active Ceased
- 2002-11-27 AU AU2002353006A patent/AU2002353006A1/en not_active Abandoned
- 2002-11-27 EP EP02789972.3A patent/EP1469888B1/en not_active Expired - Lifetime
-
2009
- 2009-12-15 JP JP2009284587A patent/JP5675088B2/ja not_active Expired - Lifetime
-
2012
- 2012-09-28 JP JP2012215505A patent/JP5829993B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010116400A5 (https=) | ||
| Beeravolu et al. | Isolation and characterization of mesenchymal stromal cells from human umbilical cord and fetal placenta | |
| JP2024041964A (ja) | 胎盤幹細胞を使用する疼痛の治療 | |
| EP2548950A3 (en) | Reprogramming T cells and hematopoietic cells | |
| ES2969240T3 (es) | Medio para formar colonias y uso de este | |
| ES3060533T3 (en) | Cell suspension and use thereof | |
| RU2017118312A (ru) | Способы и препараты для трансфекции клеток | |
| RU2018106515A (ru) | Pd-l1-экспрессирующие гемопоэтические стволовые клетки и применения | |
| NZ587809A (en) | Use of mesenchymal stem cells expressing cd73 and/or cd105 for treating genetic diseases and disorders | |
| CY1118073T1 (el) | Συνθεσεις και μεθοδοι για την αυξηση της δρασης της τελομερασης | |
| Rivera et al. | Characterization of a novel papillomavirus species (ZcPV1) from two California sea lions (Zalophus californianus) | |
| CN111647604A (zh) | 特异性识别猪COL1A1基因的gRNA及其生物材料、试剂盒和应用 | |
| WO2011028880A3 (en) | Methods for enhancing genome stability and telomere elongation in embryonic stem cells | |
| Balaji et al. | CYP1A1 genotypes and haplotypes and risk of oral cancer: A case-control study in South Indians | |
| AU2012369064A8 (en) | Methods and apparatuses harvesting, modifying and reimplantation of Dermal Micro -organs | |
| JP2012507997A5 (https=) | ||
| WO2007116408A3 (en) | Pluripotent stem cells characterized by expression of germline specific genes | |
| Sato et al. | Efficient CRISPR/Cas9-based gene correction in induced pluripotent stem cells established from fibroblasts of patients with sickle cell disease | |
| JP4652139B2 (ja) | 超低増殖性細胞株 | |
| CN102690828B (zh) | 与猪免疫性状相关的cxcl12基因片段克隆及作为分子标记的应用 | |
| John et al. | Sperm mitochondrial DNA | |
| CN1686566A (zh) | Cark基因在制备治疗心肌肥厚药物中的应用及一种抑制心肌肥厚的药物 | |
| CN101250529B (zh) | 马传染性贫血病毒可溶性受体、其编码序列、其应用 | |
| Hardouin et al. | Base editing of β0 thalassemia mutations as a therapeutic strategy for β-hemoglobinopathies: efficacy and genotoxicity studies | |
| Sufyanova et al. | Genetic Basis for Severe COVID-19 |